Šalis: Australija
kalba: anglų
Šaltinis: Department of Health (Therapeutic Goods Administration)
nicotine polacrilex, Quantity: 20 mg (Equivalent: nicotine, Qty 4 mg)
Johnson & Johnson Pacific Pty Ltd
Nicotine polacrilex
Gum, chewing
Excipient Ingredients: Carnauba Wax; xylitol; quinoline yellow aluminium lake; Peppermint Oil; Acacia; menthol; light magnesium oxide; sodium carbonate; acesulfame potassium; titanium dioxide; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides
Buccal
210, 370, 310, 15, 200, 105, 325, 315, 255, 180, 400, 270, 240, 355, 285, 385, 300, 30, 225, 340
Not scheduled. Not considered by committee
For the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus facilitating smoking cessation in smokers motivated to quit. In smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.
Visual Identification: Square coated, cream coloured piece of gum with a minty odour.; Container Type: Blister Pack; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Registered
2004-12-06